Cargando…
SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression
BACKGROUND & AIMS: SCY1-like pseudokinase 3 (SCYL3) was identified as a binding partner of ezrin, implicating it in metastasis. However, the clinical relevance and functional role of SCYL3 in cancer remain uncharacterized. In this study, we aimed to elucidate the role of SCYL3 in the progression...
Autores principales: | Lei, Martina Mang Leng, Leung, Carmen Oi Ning, Lau, Eunice Yuen Ting, Leung, Rainbow Wing Hei, Ma, Victor Wan San, Tong, Man, Lu, Yin Ying, Huang, Chen Yang, Zhu, Qiao Hua, Ng, Irene Oi Lin, Ma, Stephanie, Lee, Terence Kin Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691429/ https://www.ncbi.nlm.nih.gov/pubmed/36440258 http://dx.doi.org/10.1016/j.jhepr.2022.100604 |
Ejemplares similares
-
UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2021) -
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression
por: Ho, Nicole Pui Yu, et al.
Publicado: (2021) -
Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2022) -
Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma
por: Leung, Carmen Oi Ning, et al.
Publicado: (2023) -
Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells
por: Chung, Katherine Po Sin, et al.
Publicado: (2021)